165 related articles for article (PubMed ID: 20225394)
1. Glycaemic status influences the nature and severity of coronary artery disease.
Berry C; Noble S; Grégoire JC; Ibrahim R; Levesquie S; Lavoie MA; L'Allier PL; Tardif JC
Diabetologia; 2010 Apr; 53(4):652-8. PubMed ID: 20225394
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study.
Valenzuela-Garcia LF; Matsuzawa Y; Sara JD; Kwon TG; Lennon RJ; Lerman LO; Ruiz-Salmeron RJ; Lerman A
Cardiovasc Diabetol; 2015 Aug; 14():106. PubMed ID: 26268857
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Nitta Y; Tahara N; Tahara A; Honda A; Kodama N; Mizoguchi M; Kaida H; Ishibashi M; Hayabuchi N; Ikeda H; Yamagishi S; Imaizumi T
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1172-82. PubMed ID: 24229770
[TBL] [Abstract][Full Text] [Related]
4. Clinical predictors of atheroma progression despite optimal glycemic control in early-stage diabetic patients with coronary artery disease: Insight from the DIANA study.
Kataoka Y; Yasuda S; Miyamoto Y; Sase K; Kosuge M; Kimura K; Yoshimasa Y; Miyazaki S;
J Atheroscler Thromb; 2014; 21(5):509-18. PubMed ID: 24430787
[TBL] [Abstract][Full Text] [Related]
5. Hemoglobin A1C in non-diabetic patients: an independent predictor of coronary artery disease and its severity.
Ashraf H; Boroumand MA; Amirzadegan A; Talesh SA; Davoodi G
Diabetes Res Clin Pract; 2013 Dec; 102(3):225-32. PubMed ID: 24176244
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
[TBL] [Abstract][Full Text] [Related]
7. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease.
Sara JD; Taher R; Kolluri N; Vella A; Lerman LO; Lerman A
Cardiovasc Diabetol; 2019 Feb; 18(1):22. PubMed ID: 30819191
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound.
Kataoka Y; Shao M; Wolski K; Uno K; Puri R; Murat Tuzcu E; Hazen SL; Nissen SE; Nicholls SJ
Atherosclerosis; 2014 Feb; 232(2):377-83. PubMed ID: 24468151
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1,5-anhydroglucitol levels on culprit plaque rupture in diabetic patients with acute coronary syndrome.
Su G; Gao MX; Shi GL; Dai XX; Yao WF; Zhang T; Zhuang SW
Cardiovasc Diabetol; 2020 May; 19(1):71. PubMed ID: 32473648
[TBL] [Abstract][Full Text] [Related]
10. Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.
Kataoka Y; Shao M; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
Eur J Prev Cardiol; 2013 Apr; 20(2):209-17. PubMed ID: 22345692
[TBL] [Abstract][Full Text] [Related]
11. Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance.
Amano T; Matsubara T; Uetani T; Nanki M; Marui N; Kato M; Yoshida T; Arai K; Yokoi K; Ando H; Kumagai S; Ishii H; Izawa H; Hotta N; Murohara T
JACC Cardiovasc Imaging; 2008 Jan; 1(1):39-45. PubMed ID: 19356403
[TBL] [Abstract][Full Text] [Related]
12. Stress hyperglycaemia in hospitalized patients with coronary artery disease and type 2 diabetes risk.
Colomo N; Linares F; Rubio-Martín E; Moreno MJ; de Mora M; García AM; González AM; Rojo-Martínez G; Valdés S; Ruiz de Adana MS; Olveira G; Soriguer F
Eur J Clin Invest; 2013 Oct; 43(10):1060-8. PubMed ID: 23980841
[TBL] [Abstract][Full Text] [Related]
13. Association between increasing levels of hemoglobin A1c and coronary atherosclerosis in asymptomatic individuals without diabetes mellitus.
Rivera JJ; Choi EK; Yoon YE; Chun EJ; Choi SI; Nasir K; Brancati FL; Blumenthal RS; Chang HJ
Coron Artery Dis; 2010 May; 21(3):157-63. PubMed ID: 20308881
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of fasting blood glucose for serious coronary atherosclerosis in non-diabetic patients.
Zhao T; Gong HP; Dong ZQ; Du YM; Lu QH; Chen HQ
J Int Med Res; 2019 Jan; 47(1):152-158. PubMed ID: 30208754
[TBL] [Abstract][Full Text] [Related]
15. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology.
Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Sundvall J; Tuomilehto J; Wood D; Rydén L;
Eur Heart J; 2015 May; 36(19):1171-7. PubMed ID: 25670820
[TBL] [Abstract][Full Text] [Related]
16. Endothelial function and baroreflex sensitivity according to the oral glucose tolerance test in patients with coronary artery disease and normal fasting glucose levels.
Wykretowicz A; Guzik P; Bartkowiak G; Krauze T; Kasinowski R; Dziarmaga M; Wesseling KH; Wysocki H
Clin Sci (Lond); 2005 Oct; 109(4):397-403. PubMed ID: 15948715
[TBL] [Abstract][Full Text] [Related]
17. Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis.
Kowalska I; Prokop J; Bachórzewska-Gajewska H; Telejko B; Kinalskal I; Kochman W; Musial W
Diabetes Care; 2001 May; 24(5):897-901. PubMed ID: 11347751
[TBL] [Abstract][Full Text] [Related]
18. Fasting Blood Glucose and HbA
Yang J; Zhou Y; Zhang T; Lin X; Ma X; Wang Z; Liu Y; Shi D; Zhou Z; Zhao Y
Angiology; 2020 Feb; 71(2):167-174. PubMed ID: 31749367
[TBL] [Abstract][Full Text] [Related]
19. High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
Daida H; Takayama T; Hiro T; Yamagishi M; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
Cardiovasc Diabetol; 2012 Jul; 11():87. PubMed ID: 22831708
[TBL] [Abstract][Full Text] [Related]
20. Lifetime glycaemic exposure predicts reduced coronary vasoreactivity in Type 1 diabetic subjects.
Sundell J; Janatuinen T; Rönnemaa T; Naum A; Laine H; Luotolahti M; Nuutila P; Raitakari OT; Knuuti J
Diabet Med; 2005 Jan; 22(1):45-51. PubMed ID: 15606690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
